Information Provided By:
Fly News Breaks for February 14, 2020
Feb 14, 2020 | 07:36 EDT
Cantor Fitzgerald analyst Alethia Young raised her price target for Agios Pharmaceuticals to $70 from $64 after the company reported Q4 results and provided a strategic update and long-term guidance. The analyst says the Tibsovo guidance gives her greater confidence in both near- and long-term top-line growth. She reiterates an Overweight rating on Agios.
News For AGIO From the Last 2 Days
There are no results for your query AGIO